Britta Engelhardt obtained a degree in Human Biology at the Medical School of the Philipps-University, Marburg in Germany in 1987. She performed her PhD thesis in the laboratory of Hartmut Wekerle (Max-Planck Clinical Research Group for Multiple Sclerosis, Würzburg and Max-Planck Institute for Psychiatry, Martinsried, Germany) and obtained a PhD in Human Biology (Dr.rer.physiol.) in January 1991. After a post-doctoral fellowship in the laboratory of Eugene C. Butcher at Stanford University, California, she set up her own research group at the Max-Planck Institute for Physiological and Clinical Research, Bad Nauheim, Germany in the department of Werner Risau (†December 13th, 1998) in 1993. In 1998 she obtained the Venia Legendi for Immunology and Cell Biology from the Medical Faculty of the Philipps University Marburg, Germany. From 1999 to 2003 she headed her research group as a senior group leader at the same institute and the Max-Planck-Institute for Vascular Cell Biology, Münster, Germany. Since November 2003 Britta Engelhardt is Professor for Immunobiology at the University of Bern and the Director of the Theodor Kocher Institute. Britta Engelhardt is an expert in blood-brain barrier (BBB) biology with a special focus on neuroinflammatory processes at the BBB. She has pioneered the use of intravital microscopy of the CNS white matter microcirculation allowing study of leukocyte/BBB interaction real time in live mice. She received the Herrmann-Rein Award of the Society for Microcirculation and Vascular Biology in 2001 for this work. Britta Engelhardt currently coordinates the FP7 funded Collaborative Project JUSTBRAIN investigating options for paracellular drug delivery across the BBB.